Patent · US Active

Treatment of skin lesions

US10993947B2 · kind B2 · utility

1Cited by
0References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 17, 2017
Grant dateMay 4, 2021
Priority date
Expiry dateJun 12, 2037

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P17/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is relates to a compound of formula (I), wherein wherein the arrow denotes the bond in formula (I); and wherein R3 and R4 are independently of each other H, C1-C3alkyl optionally substituted with one or two OH, C1-C2fluoroalkyl, C1-C2alkoxy, C1-C2alkoxyC1-C3alkyl, CN, or C(O)O—C1-C2alkyl; or R3 and R4 form together a bivalent residue —R5R6— selected from C1-C3alkylene optionally substituted with 1 to 4 F, —CH2—O—CH2—, —CH2—NH—CH2—, or any of the structures wherein the arrows denote the bonds in formula (II); or

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.